Invest in

Biotech Breakthroughs

14.1%
9.1%
0.8%

Feeling Better About Biotech

The next big cure for a complex, scary disease is unlikely to come from old-school pharma. It’s likely coming from biotech. Scientists, investors, and patients are all banking on the $93 billion biotech industry.[1] It’s outpaced Big Pharma in finding treatments for cancer, AIDS, multiple sclerosis, and other diseases. The FDA approved 43 drugs in 2012, a 20% jump from the previous year.[4] Big Pharma has responded by snapping up promising biotech and smaller pharmaceutical companies, at lofty valuations, with premiums for several public companies in excess of 50%.[2] In fact, 2013 was a big year for the biotech industry, with $29B in M&A deals through the 1st half of 2013.[3] This motif includes only biotech companies with at least two years of cash flow to help screen out companies at greater risk of losing money. See more
14.1%
9.1%
0.8%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Biotech Breakthroughs Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
35.6% Cancer 2.3%
20.6% Amgen Inc AMGN 1.2%
11.3% Celgene Corp. CELG 6.2%
2.2% Seattle Genetics Inc. SGEN 5.4%
1.6% Spectrum Pharmaceuticals, Inc. SPPI 16.2%
19.7% Infectious Diseases 13.1%
17.0% Gilead Sciences Inc. GILD 15.5%
1.6% Emergent Biosolutions Inc. EBS 23.9%
1.1% Opko Health Inc. OPK 29.4%
17.3% Other Diseases 16.5%
5.8% Alexion Pharmaceuticals Inc. ALXN 16.1%
5.5% Regeneron Pharmaceuticals Inc. REGN 22.5%
2.8% Vertex Pharmaceuticals Incorporated VRTX 34.0%
1.6% United Therapeutics Corporation UTHR 36.3%
1.6% Ligand Pharmaceuticals Incorporated LGND 55.0%
15.6% Autoimmune Disorders 30.0%
10.0% Biogen Inc BIIB 31.8%
2.2% BioMarin Pharmaceutical Inc. BMRN 27.9%
2.2% Incyte Corp. INCY 29.6%
1.2% Xencor Inc XNCR 19.9%
11.8% Research & Diagnostics 8.5%
3.9% Quintiles Transnational Holdings Q 0.7%
3.6% Illumina Inc. ILMN 27.8%
2.9% Qiagen N.V. QGEN 8.6%
1.5% Meridian Bioscience Inc. VIVO 14.2%

Quotes delayed 15 mins. Currently May 6, 2016 10:57:43 AM. Fields are marked with -- when data is unavailable.